Our study attempted to determine whether polymorphisms in selected genes important for selenium metabolism, GPX1 (rs1050450), DIO2 (rs225014) and SEPP1 (rs7579), are associated with the risk of developing endometrial cancer. This evidence concerns the gene GPX1 and endometrial cancer.